Antagonism of GABA-mediated inhibition in the central nervous system by caprolactam derivatives.
D000613:Aminobutyrates / Q000037:antagonists & inhibitors*; D000818:Animals; D001381:Azepines / Q000494:pharmacology*; D001921:Brain / Q000187:drug effects*; D002209:Caprolactam / Q000031:analogs & derivatives / Q000494:pharmacology*; D005071:Evoked Potentials / Q000187:drug effects; D018756:GABA Antagonists; D009433:Neural Inhibition / Q000187:drug effects*; D010852:Picrotoxin / Q000494:pharmacology; D011817:Rabbits; D012640:Seizures / Q000139:chemically induced; D013329:Structure-Activity Relationship; D013378:Substantia Nigra / Q000187:drug effects
D000613:Aminobutyrates; D001381:Azepines; D002209:Caprolactam; D018756:GABA Antagonists; D010852:Picrotoxin